Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors

Kidney Int Rep. 2023 Jun 8;8(9):1892-1898. doi: 10.1016/j.ekir.2023.06.001. eCollection 2023 Sep.

Rayane Benyahia¹, Helene Lazareth^{2

3}, Adrien Flahault^{2

3}, Vesna Brglez^{4

5

6}, Barbara Seitz-Polski^{4

5

6

7}, Samy El Fil⁸, Julien Mazières^{9

10}, David Ribes¹, Antoine Huart¹, Magali Colombat^{10

11}, Alexandre Karras^{2

3}, Julie Belliere^{1

10}

¹ Department of Nephrology and Organ Transplantation, Referral Center for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France.
² Department of Nephrology, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
³ Université Paris Cité, Paris, France.
⁴ Reference Center for Rare Diseases Idiopathic Nephrotic Syndrome, Nice University Hospital, Nice, France.
⁵ UR2CA Clinical Research Unit-Team ImmunoPredict, Côte d'Azur University, Nice, France.
⁶ Immunology Laboratory, Archet 1 Hospital, Nice University Hospital, Nice, France.
⁷ Department of Nephrology Dialysis and Transplantation, Pasteur 2 Hospital, Nice University Hospital, Nice, France.
⁸ Centre Hospitalier Intercommunal des Vallées de l'Ariège, Saint Jean de Verges, France.
⁹ Department of Pneumology, Larrey Hospital, University Hospital of Toulouse, Toulouse, France.
¹⁰ University Paul Sabatier-Toulouse 3, Toulouse, France.
¹¹ Department of Pathology, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.

No abstract available

Publication types